These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24100864)

  • 1. Association of white matter deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized VBM study using 3T.
    Yao L; Lui S; Deng W; Wu M; Chen L; Xiao Y; Lama S; Zhang W; Huang X; Li T; Gong Q
    MAGMA; 2014 Aug; 27(4):283-90. PubMed ID: 24100864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
    Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
    Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter microstructure alterations of the posterior limb of internal capsule in first-episode drug naive schizophrenia patients.
    Ding Q; Li L; Tong Q; He H; Gao B; Xia L
    Brain Res; 2024 Oct; 1841():149114. PubMed ID: 38977237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting.
    Leung M; Cheung C; Yu K; Yip B; Sham P; Li Q; Chua S; McAlonan G
    Schizophr Bull; 2011 Jan; 37(1):199-211. PubMed ID: 19759093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional white matter abnormalities in drug-naive, first-episode schizophrenia patients and their healthy unaffected siblings.
    Lyu H; Hu M; Eyler LT; Jin H; Wang J; Ou J; Guo X; He Z; Liu F; Zhao J; Guo W
    Aust N Z J Psychiatry; 2015 Mar; 49(3):246-54. PubMed ID: 25318995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive brain structural changes after the first year of treatment in first-episode treatment-naive patients with deficit or nondeficit schizophrenia.
    Lei W; Kirkpatrick B; Wang Q; Deng W; Li M; Guo W; Liang S; Li Y; Zhang C; Li X; Zhang P; Li Z; Xiang B; Chen J; Hu X; Zhang N; Li T
    Psychiatry Res Neuroimaging; 2019 Jun; 288():12-20. PubMed ID: 31059954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter volume change and its correlation with symptom severity in patients with schizophrenia: a VBM-DARTEL study.
    Kim GW; Jeong GW
    Neuroreport; 2015 Dec; 26(18):1095-100. PubMed ID: 26485094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.
    Wang Q; Cheung C; Deng W; Li M; Huang C; Ma X; Wang Y; Jiang L; Sham PC; Collier DA; Gong Q; Chua SE; McAlonan GM; Li T
    Psychol Med; 2013 Nov; 43(11):2301-9. PubMed ID: 23442742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
    Yue Y; Kong L; Wang J; Li C; Tan L; Su H; Xu Y
    PLoS One; 2016; 11(1):e0147204. PubMed ID: 26789520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of regional homogeneity and its correlation with clinical symptoms in Naïve patients with first-episode schizophrenia.
    Zhao X; Yao J; Lv Y; Zhang X; Han C; Chen L; Ren F; Jin Z; Li Y; Sui Y
    Brain Imaging Behav; 2019 Apr; 13(2):503-513. PubMed ID: 29736883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole brain volume changes and its correlation with clinical symptom severity in patients with schizophrenia: A DARTEL-based VBM study.
    Kim GW; Kim YH; Jeong GW
    PLoS One; 2017; 12(5):e0177251. PubMed ID: 28520743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study.
    Hu M; Zong X; Zheng J; Mann JJ; Li Z; Pantazatos SP; Li Y; Liao Y; He Y; Zhou J; Sang D; Zhao H; Tang J; Chen H; Lv L; Chen X
    Psychol Med; 2016 Sep; 46(12):2549-60. PubMed ID: 27338296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
    Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
    J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
    Ebdrup BH; Raghava JM; Nielsen MØ; Rostrup E; Glenthøj B
    J Psychiatry Neurosci; 2016 Mar; 41(2):133-41. PubMed ID: 26599135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reduction of gray and white matters in patients with temporal lobe epilepsy and its correlation with disease duration].
    Lu JJ; Li WJ; He HG; Feng F; Jin ZY; Wu LW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Jun; 35(3):286-93. PubMed ID: 23827066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
    Anderson VM; Goldstein ME; Kydd RR; Russell BR
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects.
    Bergé D; Carmona S; Rovira M; Bulbena A; Salgado P; Vilarroya O
    Acta Psychiatr Scand; 2011 Jun; 123(6):431-9. PubMed ID: 21054282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study.
    Zhang XY; Fan FM; Chen DC; Tan YL; Tan SP; Hu K; Salas R; Kosten TR; Zunta-Soares G; Soares JC
    J Clin Psychiatry; 2016 Feb; 77(2):205-11. PubMed ID: 26761708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease.
    Zhao C; Zhu J; Liu X; Pu C; Lai Y; Chen L; Yu X; Hong N
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():27-32. PubMed ID: 29292241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.